Creo House
Unit 2, Beaufort Park Beaufort Park Way
Chepstow NP16 5UH
United Kingdom
44 12 9160 6005
https://creomedical.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Craig Jonathan Gulliford | CEO & Executive Director | 472.66k | N/A | 1970 |
Prof. Christopher Paul Hancock | Founder, CTO & Executive Director | 360.17k | N/A | 1967 |
Mr. Richard John Rees ACA | CFO, Company Secretary & Executive Director | 359.8k | N/A | 1976 |
Mr. David Gerard Woods | Chief Commercial Officer & Executive Director | 446.38k | N/A | 1965 |
Mr. Phil Hales | Sales & Marketing Director | N/A | N/A | N/A |
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for flexible endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device designed for soft tissue ablation; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highly perfused tissues. In addition, it provides endotherapy accessories comprising ScopeSnare, an energy-based polypectomy snares; ScopeSnare Cold, a cutting wire for use in endoscopically in the removal of diminutive, sessile and pedunculated polyps, and tissue from within the GI tract; ScopeClip, a single-use rotational and repositionable hemoclips; ScopeBite, a portfolio of biopsy forceps; ScopeGrasp, a portfolio of grasping forceps; and ScopeInject, an injection needle. Creo Medical Group PLC was founded in 2003 and is based in Chepstow, the United Kingdom.
Creo Medical Group PLC’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.